retatrutide phase 2 trial type 2 diabetes weight loss VisualAbstract: reduces body by 17.5% in patients with obesity Retatrutide Weight Loss Results:Trial Data

Judy Korner, an endocrinologist at NewYork-Presbyterian/Columbia University Irving Medical Center

This law dates back to 2003, around the time of the fen-phen scandal, when it was found to cause serious heart problems

Retatrutide: Phase II data showed up to 24.2% body weight reduction in only 48 weeks

The synbiotic design targets the microbiome rather than forcing rapid metabolic changes, which appeals to consumers looking for a gradual, sustainable strategy alongside balanced nutrition and physical activity

Key Differences in Efficacy, Side Effects, and Tolerability Efficacy comparisons show tirzepatide achieves superior weight loss outcomes in head-to-head analysis